Latest Renewables News

Amplia Therapeutics has successfully raised A$25 million through an institutional placement and launched a A$2.5 million Share Purchase Plan to fund pivotal clinical trials of its lead drug narmafotinib. The capital injection positions the company to advance key pancreatic and ovarian cancer studies into 2027.

Aerometrex has completed a strategic review that delivers $2 million in cost savings and initiates data monetisation, positioning the company for accelerated growth in FY26.

Highfield Resources has entered a significant non-binding agreement with China’s Qinghai Salt Lake Industry for a US$300 million equity injection, aiming to fast-track its Muga potash mine development and expand its global footprint.

GenusPlus Group has won an additional $60 million contract extension from Western Power, reinforcing its role in expanding WA’s renewable energy transmission network.

QPM Energy has successfully raised $7 million through an oversubscribed Share Purchase Plan, significantly exceeding its initial $2 million target to accelerate key gas power projects in Queensland.

Astron Corporation has released updated economics for its Donald Rare Earth and Mineral Sands Project, showcasing robust financial metrics and targeting a Final Investment Decision by late 2025 with production slated for 2027.

Race Oncology has safely treated the first patient with its RC220 drug alone and in combination with doxorubicin in a Phase 1 trial, while bolstering its clinical leadership and maintaining a strong cash position to fund operations through 2026.

Mitchell Services Limited reported a robust fourth quarter with strong cash flow driving a significant net debt reduction, while its Loop decarbonisation joint venture gains momentum with new contracts.

Vulcan Energy has won up to €104 million in grants from German federal and state governments to advance its sustainable lithium production project, bolstering Europe’s electric vehicle battery supply chain.

Invex Therapeutics has broadened its collaboration with Tessara Therapeutics to explore Exenatide’s potential in Alzheimer’s disease, while successfully renewing key orphan drug designations in Europe and the US.

MOVE Logistics Group has achieved its FY25 financial targets, showcasing significant improvements in earnings and operational efficiency despite a tough economic backdrop in New Zealand.

Strata Minerals Limited is set to recommence diamond drilling at its Penny South Gold Project in Western Australia, aiming to build on promising initial results. The program, co-funded by the WA government, marks a critical step in advancing exploration with new structural insights expected.